Where do those data go? Reuse of screening results from clinical trials to estimate population prevalence of HBV infection in adults in Kilifi, Kenya-Reference-Cited by-同舟云学术

Where do those data go? Reuse of screening results from clinical trials to estimate population prevalence of HBV infection in adults in Kilifi, Kenya

Published:2023-12 Issue:4 Volume:9 Page:100355
ISSN:2055-6640
Container-title:Journal of Virus Eradication
language:en
Short-container-title:Journal of Virus Eradication

Author:

Downs Louise O.^ORCID,Campbell Cori,Abouyannis Michael,Otiende Mark,Kapulu Melissa,Obiero Christina W.,Hamaluba Mainga,Ngetsa Caroline,Andersson Monique I.,Githinji George,Warimwe George,Baisley Kathy,Scott J. Anthony G.,Matthews Philippa C.,Etyang Anthony

Funder

Francis Crick Institute

John Fell Fund, University of Oxford

University College London Hospitals Biomedical Research Centre

NIHR Imperial Biomedical Research Centre

Wellcome Trust

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Public Health, Environmental and Occupational Health,Immunology,Epidemiology

Reference18 articles.

1. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019;Abbafati;Lancet,2020

2. Prevalence and predictors of hepatitis B virus (HBV) infection in east Africa: evidence from a systematic review and meta-analysis of epidemiological studies published from 2005 to 2020;Kafeero;Arch Publ Health,2021

3. Prevalence of hepatitis B virus infection in Kenya, 2007;Ly;Am J Trop Med Hyg,2016

4. Profile: the Kilifi Health and Demographic Surveillance System (KHDSS);Scott;Int J Epidemiol,2012

5. TRUE-1: trial of Repurposed Unithiol for snakebite Envenoming phase 1 (safety, tolerability, pharmacokinetics and pharmacodynamics in healthy Kenyan adults);Abouyannis;Wellcome Open Res,2022